Seer

Biotechnology company that offers tools and solutions related to the field of proteomics

Stránky společnosti

Ticker

SEER.NASDAQ

Trh

Rok založení

2017

Uzávěrka

12/20/2020

Datum IPO

12/3/2020

Cena umístění

$19

Ziskovost

195.53%

O společnosti

Total Funding

$169.5M

Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.

Number of employees

51-100

Headquarters

Redwood City, California, United States